Can You Trust CannTrust (TSX:TRST)?

It is pretty ironic that a company named CannTrust (TSX:TRST)(NYSE:CTST) broke the trust of its investors. Health Canada suspended CannTrust’s licence to grow marijuana after reports that it illegally grew weed in unlicensed rooms.

This scandal lead to the firing of the CEO and many other senior management. At the end of the day, though, I am willing to forgive CannTrust for what the company has done.

It is no secret that governments are extremely bureaucratic. The process to get things done through a government agency is a job in itself! By operating the illegal grow rooms, CannTrust was able to accept much more business than it would have without them.

Given that Health Canada is a governmental organization, who knows how long it would have taken for the rooms to be licensed? By that time, the contracts could have been awarded to other companies.

While I absolve CannTrust of its guilt, it remains a poor investment due to the lack of ethics by senior management and tight cash reserves.

Lack of ethics

I know I’ve spent the first several paragraphs justifying the actions of CannTrust; however, at the end of the day, this scandal indicates that senior management seriously need ethics training.

I agree that senior management likely had the interest of investors in mind; however, with its current stock price, I can emphatically say that senior management has failed in that regard.

The issue with a scandal like this is it begets the question, “what else is the company hiding?”

An executive team with the audacity to dupe a government agency and the public certainly has other skeletons in its closet. The problem with this is investors never know if it is likely to benefit them down the road or harm them.

As an investor, I appreciate stability when investing in a company. Not in the sense of blue-chip, 100-year-old companies, but rather companies that don’t surprise you.

The reason for this is because no surprises are good surprises. Even if a company releases news that causes the share price to increase and investors to make double-digit returns, that is due to dumb luck. It very well could have gone the other way.

Thus, CannTrust and its unethical management team is not an investment that I would consider.

Tight cash reserves

Given that Health Canada has suspended its licence to grow any more weed, CannTrust needs to have massive cash reserves to maintain its current operations.

The company ended fiscal 2018 with $9 million in cash, which is not good. With operating expenses of $45 million in fiscal 2018 and current liabilities of $17 million, the company will be on the hook for $62 million of expense and liabilities in fiscal 2019, which cannot be met with current cash reserves.


CannTrust has dropped the ball in a big way. Senior management’s lack of ethics and the company’s tight cash reserves jeopardizes its ability to recover from this setback.

Unfortunately, a lack of ethics at the top permeates into the corporate culture, which means that even with the CEO and many senior management gone, it is very likely that the “cutting-corners” mentality will remain with the current employees.

This is definitely a stock to avoid.

If you liked this article, click the link below for exclusive insight.

One tiny small-cap stock to bet on ahead of Cannabis 2.0 on October 17th…

The first wave of cannabis legalization minted millionaires out of everyday investors, and it might be about to happen again.

Because when edibles are legalized in Canada on October 17th, experts project a new $2.7 BILLION market will be born.

Our last legalization stock pick is already up 1,211%, and now we’re recommending one tiny small-cap stock before Cannabis 2.0.

This could be our next +1,000% winner in the cannabis space.

Hurry, the second wave of cannabis legalization is about to hit and this stock could skyrocket.

Click here to learn more!

More reading

Fool contributor Chen Liu has no position in any of the stocks mentioned.

Source: The Fool
Can You Trust CannTrust (TSX:TRST)?
The Fool

The Motley Fool
Contributor at
The Motley Fool is dedicated to helping the world invest — better. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, mutual funds, and premium investing services.

In all we do, we take a different approach.

We believe – and have proven over decades – that the individual investor can beat the market.

We believe that anyone can do it, even if they don’t have a lot of time or money to devote to investing.

We believe in a long-term outlook, helping people build wealth over time.

We believe that the person best positioned to take care of your financial future is you.

And we work tirelessly on behalf of our hundreds of thousands of members who are enjoying the opportunities that come with having enough money to do the things that matter to them.

While we are headquartered in Alexandria, Va., The Motley Fool advocates for the individual investor around the globe with offices in the UK, Australia, Canada, Singapore, and Germany.

Related News